Skip to main content
. 2015 Sep 22;182(2):184–194. doi: 10.1111/cei.12679

Figure 2.

Figure 2

Increased prevalence of neutrophils expressing CD11c, epidermal growth factor (EGF)-like molecule containing mucin-like hormone receptor (EMR2) and CD64 in patients with the systemic inflammatory response syndrome (SIRS) and sepsis. Results are expressed as either the mean percentage of neutrophils ± standard deviation (s.d.) or as the mean fluorescence intensity (MFI) ± s.d. In (a) the percentage of neutrophils bearing CD11c, EMR2 and CD64 was higher in 103 patients with SIRS when compared with 50 healthy control subjects. *P < 0·001. (b) The percentage of neutrophils bearing CD62L and CD97 and the MFIs of CD11a and CD11b were similar for both groups of subjects. (c) When the patients with SIRS were categorized into those without infection (n = 20) and those with sepsis (n = 83), the prevalence of neutrophils bearing CD11c or CD64 was greater in the sepsis group when compared with patients without infection. *P < 0·001.